Compounds / PEG-MGF

PEG-MGF

Also known as: PEGylated Mechano Growth Factor

No human data Not FDA-approved Category: Growth Factors

The compounds described in this library are research-use-labeled chemicals and are not FDA-approved for human use. This content is factual scientific reference drawn from published literature. It is not medical, dosing, or purchasing advice. VialReport does not sell, supply, or distribute any compound.

Short summary

"PEG-MGF" is a research-market name rather than a single well-defined substance. Public listings generally do not specify PEG molecular weight, attachment site, conjugation ratio, linker chemistry, or degree of substitution. There is no established human pharmacokinetic or clinical evidence for the marketed material.

Dive deeper

Origin and Development

The stated rationale in the market is that attaching polyethylene glycol to MGF slows clearance and extends activity. That rationale is plausible in general pegylation terms, but it is worth being clear that this describes a concept rather than a characterized product: the cited MGF literature concerns unpegylated material, and there is no defined PEG-MGF reference product behind the name.

Mechanism as Understood in the Literature

Presumed to be the same as MGF, with pegylation altering pharmacokinetics rather than underlying activity. That presumption has not been demonstrated for the marketed material, and the underlying MGF mechanism is itself contested.

Research Status

No human pharmacokinetic, pharmacodynamic, or toxicological data exists for PEG-MGF. The literature usually cited in support of it concerns unpegylated MGF concepts rather than a defined pegylated product.

Regulatory status

Not FDA-approved for any indication. Prohibited in competitive sport under World Anti-Doping Agency rules.

Commonly Confused With

Distinct from unmodified MGF, and from IGF-1 and IGF-1 LR3. The more important point is that PEG-MGF is not a single defined molecule in the way most entries in this library are. [DECISION NEEDED: whether VialReport should issue an identity or purity grade for PEG-MGF at all without first defining an exact target specification.]

How This Compound Is Marketed

Vendor marketing for this compound typically references muscle repair and recovery, positioned as a longer-acting version of MGF. VialReport does not evaluate or endorse these claims. See Research Status above for what the published literature actually establishes.

Analytical Profile

This is the analytically hardest compound in this group, and worth understanding before drawing conclusions from any test result. The PEG conjugation site, the molecular weight of the PEG chain, and the linker chemistry all vary between preparations. That means two vials both labeled PEG-MGF may contain genuinely different molecules with different masses, rather than the same molecule at different purities. Pegylated compounds also produce broader, less defined chromatographic peaks than unmodified peptides, because PEG chains are themselves polydisperse. Purity figures for pegylated material should be interpreted with that in mind.

Stability and Handling

Supplied lyophilized. Claims that pegylation improves in-solution stability here are extrapolated from pegylation in general rather than demonstrated for this material. Stability depends on molecular form, formulation, moisture, container closure, temperature, and reconstitution conditions.

Key Literature

  1. 01 Yang SY, Goldspink G. Different roles of the IGF-I Ec peptide (MGF) and mature IGF-I in myoblast proliferation and differentiation. FEBS Lett. 2002;522(1-3):156-160.
  2. 02 Goldspink G. Mechanical signals, IGF-I gene splicing, and muscle adaptation. Physiology. 2005;20:232-238.

VialReport publishes factual reference information and independent test data. Nothing here is medical, dosing, or purchasing advice.

Published reports

Reports for PEG-MGF

No reports for this compound yet.

Want a vendor’s version of this compound tested? Request it and we’ll notify you when a report publishes.

Request a test

Stay current

Get notified when new reports publish.

No membership required. We email findings when they're published. Not updates, not promotions, just reports.

Powered by MailerLite. No spam. Unsubscribe anytime.